 Development antibodies recurrent bleeding patient topical bovine thrombin year old patient topical bovine thrombin cardiac surgery clotting times severe bleeding diathesis studies normal plasma clotting times Platelet transfusions immunosuppressive immunomodulatory therapies ineffective plasmapheresis effective times resolution clinical bleeding events patient purified IgG bovine thrombin enzyme-linked immunosorbent assay ELISA IgG human thrombin view severe bleeding coexisting inhibitor patient factor activity normal normal plasma presence inhibitor factor patient IgG bovine human factor Immunoblotting site antibody light chain activated bovine factor Detectable amounts bovine factor commercial bovine thrombin preparations ELISA data suggest patients topical bovine thrombin antibodies Anti-thrombin antibodies factor inhibitors responsible clinical bleeding